PANAChE Home

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit , please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Welcome to the PANAChE Database of the Epilepsy Therapy Screening Program

This resource contains public and non-confidential chemical structures and biological testing data for compounds that have been screened for efficacy and tolerability in test assays for epilepsy and related seizure disorders as part of the Epilepsy Therapy Screening Program (ETSP) in the Division of Translational Research, National Institute of Neurological Disorders and Stroke (NINDS).

ETSP is the new name for the program known for forty years as the Anticonvulsant Screening Program (ASP). The program was renamed in 2015 to reflect the emphasis on identifying differentiated therapeutic agents to address the unmet medical needs of epilepsy, specifically drug resistant epilepsy, special epilepsy populations, disease prevention and modification. Please refer to the ETSP public website for further detailed information about the ETSP including applying to the program.

Test compounds and data are being added to the PANAChE database on an ongoing basis. It is important to emphasize that compounds submitted to the ETSP are evaluated after a written agreement between the NINDS and the ETSP participant. As such, proprietary compound structures and data generated by the ETSP are included in PANAChE only with written permission from the program participant.

PANAChE has a SEARCH function, which allows you to search the PANAChE database for information on specific compounds, compound classes, etc. When a specific compound is identified, links in the data summaries can then be followed to obtain more detailed information about results in specific tests, including access to the raw data. The value of PANAChE as a drug discovery tool will increase as more compounds are added to the database over time.

In addition to compound information, PANAChE contains descriptions of the current and past assays used to screen compounds in the ETSP. The overall intent is to provide accurate information on tests used for compounds in PANAChE, regardless of when that testing occurred.